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The central role of the thymus and of thymus-derived lymphocytes in cell-mediated 
immunity has been well established (1).  Besides the production by the  thymus  of 
lymphocytes endowed with specific immunological properties, there is an increasing 
body of evidence in favor of the existence of a hormonal mechanism in thymic func- 
tion. This concept is based on the specific capacity of thymus extracts to partially 
repair the immunological damage induced by thymectomy (2-4).  Moreover,  it has 
been shown that thymic extracts play an essential role in the differentiation processes 
that  lead immature  lymphoid elements towards acquisition of immunocompetence 
(5,  6).  Previous  observations from  this  laboratory have  suggested  that  a  thymic 
humoral factor (THF) 1 acts upon young T  lymphocytes and transforms them into 
immunologically reactive cells, when their capacity to induce a graft-vs.-host reaction 
(GVHR) and to cooperate with B  lymphocytes for antibody synthesis was measured 
(7, 8). 
Mouse lymphoid cells sensitized in vitro against allogeneic fibroblasts were shown 
to mediate  specific in vitro cytotoxicity against these  cells (9),  as well as in vivo 
rejection of tumors genetically related to  the  sensitizing fibroblasts used  (10).  We 
have recently described a  similar in vitro cell-mediated reaction of mouse lympho- 
cytes against syngeneic tumor cells (11).  In  this particular system,  spleen cells of 
C57BL  strain origin were cultured on 3LL Lewis tumor monolayers and tested for 
cytotoxicity according to the microassay described by Takasugi and Klein (12).  It 
was found that these lymphoid cells exerted, under the experimental conditions used, 
specific cytotoxicity against 3LL Lewis tumor target cells. 
It was, therefore, interesting to investigate to what extent THF participates 
in the process that leads uncommitted lymphoid cells to the level of cells spe- 
cifically sensitized  against  cell  targets,  by  using  the  in  vitro  model  of  cell- 
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Fund, Jerusalem, and by the National Institutes of Health, agreement NCI-G-72-3890. 
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mediated  response mentioned  above.  Since this reaction can be separated  into 
two  main  phases,  namely,  sensitization  and  cytotoxicity,  we  have  tested  the 
effect of THF  on each of these phases. In addition, experiments were aimed at 
characterizing  the type  of lymphocyte  involved in  this cell-mediated  reaction 
and  defining  the cell population  activated  by THF. 
Materials and Methods 
M~e.--2-mo  old  inbred  male  and  female  C57BL/6J  mice  were  used  as  the  source  of 
lymphoid cells.  In one experiment, mice of the same strain, thymectomized at 1 day of age 
according to the technique of Miller (13),  were used as donors of spleen cells.  In a  series of 
experiments involving the use of T  or B  lymphocytes,  the donors were previously thymec- 
tomized at the age of 6-8 wk by the technique described by Gross (14). 
Irradiation.--Mice  were submitted 7  days  after adult  thymectomy  to  a  total body ex- 
posure of 750 R  from a  6°Co source (gamma beam 150 A, Atomic Energy of Canada Ltd., 
Ottawa, Ontario, Canada) 60 R/min, focal skin distance 34 inches. 
Preparation of Lymphoid Cells.--Spleens and thymuses were gently pressed through a fine 
stainless  steel mesh.  The  cells,  suspended  in  Dulbecco's modified  Eagle's  medium  (EM), 
were filtered through a  metal sieve and washed twice in EM. Bone marrow cell suspensions 
were obtained from pooled tibiae and femora. The marrow was discharged by forcing a solu- 
tion of EM through the bone cavity. The cells obtained were separated by passage through a 
27 gauge needle, filtered on a  metal sieve, and washed twice by centrifugation. All the cell 
suspensions prepared  were  submitted  to  the  trypan  blue  exclusion  test for  evaluation  of 
viabifity. 
Preparation of Sensitizing Cell Monolayers.--The  3LL Lewis tumor was used as the target 
for sensitization. This is a lung carcinoma, which arose spontaneously in a C57BL mouse (15). 
This tumor has been maintained in our laboratory by serial passage in syngeneic C57BL/6J 
male mice.  2 wk  after subcutaneous inoculation, the local tumor was aseptically removed, 
minced with scissors, and trypsinized for 30 min in a  0.25%  solution of  trypsin.  5  X  106 
3LL tumor cells were resuspended in 4 ml of Waymouth's medium supplemented with 5% 
calf serum  and  plated  on  60-ram  plastic Petri dishes  (Falcon  Plastics,  Div.  of  BioQuest, 
Oxnard, Calif.). In one experiment, rat BN fibroblasts were prepared as previously described 
(16) and seeded onto 60-mm Petri dishes in Waymouth's medium, plus 5% calf serum. 
Spleen Cell Sensitization.--Tumor  cell and  fibroblast monolayers were  irradiated  before 
sensitization with 8,000 and 2,000 R, respectively. 24 h  later, the medium was removed and 
30  X  106 viable spleen cells, suspended in 4 ml of EM  supplemented with fetal calf serum 
(FCS)  (Armour Pharmaceutical Co., Chicago, Ill.), were poured onto the sensitizing mono- 
layers and incubated at 37°C in humidified air plus 10% CO2. After 20 h  of incubation, the 
culture medium was changed, and fresh medium added. On the 4th day, the sensitized lymph- 
oid ceils were removed by gently pipetting, washed twice in EM, and counted. From 10 to 
20% of the initial spleen cell inoculum was usually recovered, 60 to 80% of which was viable 
according to the trypan blue exclusion test. 
In Vitro Assay of Cytoxicity.--The  technique described by Takasugi and Klein (12), with 
some modifications, has been presently used.  1,000-2,000 trypsinized 3LL tumor cells from a 
freshly explanted  tumor were pipetted with a  10  /zl microdispenser  (Oxford  Laboratories, 
Foster City, Calif.) into the wells of microplates (Falcon microtest tissue culture plate 3034). 
24 h later, approximately 10% of the tumor cells attached to the plastic bottom of the wells 
and appeared as typical flattened spindle-shaped ceils.  The medium was removed from each 
well by suction, and spleen cells were dispensed into the holes of the microplate and incu- 
bated for 20-40 h. The number of surviving target ceils was recorded in the following way: 
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tilted in order to remove the nonadherent cells. The excess of medium was then poured out 
and  the  microplates  were  examined  under  an  inverted  phase-contrast  microscope.  Only 
flattened spindle-shaped  target cells were recorded as viable cells,  since it was found previ- 
ously that  the majority of the rounded  tumor cells stains positively with trypan  blue and 
eosin Y  (11). The accuracy of the assay was increased by precounting the number of tumor 
spindle cells before the addition of spleen cells. The number of surviving tumor cells divided 
by the precount of the same well gave a  ratio that reduced the effect of varied tumor cell 
plating on the experimental data. A cytotoxicity index was calculated as follows: 
no. of target cells in control group -- no. of target cells in test group X  100. 
no. of target cells in control group 
Statistical significance  between groups representing the mean of the number of cells counted 
in 6-10 wells was determined by Student's t test. 
Titration of Celts Bearing O-A ntigen and Lymphocyte  A ctivation by Concanavalin A (Con  A) .-- 
Anti-0 serum was obtained from AKR/J mice hyperimmunized with C3H/eb  thymocytes. 
The reaction was performed in an excess of antiserum plus complement and  read with the 
addition of trypan blue.  Con A stimulation was performed as follows: 5  X  106 spleen cells 
in  1 ml of EM plus  10%  FCS were incubated  for 72 h  in the presence of 2 #g of Con A 
(Miles-Yeda, Rehovot, Israel).  2 h  before the end of the reaction, 2 /zCi of [~H]thymidine 
(Amersham, England) were added to the cultures, which were gently shaken in a 37°C water 
bath.  The cells were  then  poured  onto fiberglass  filters  (Wathman,  England)  and  rinsed 
successively with saline, a cold solution of 5% TCA, and absolute ethanol. The filters were 
dried and counted  in 2,5-diphenyloxazole  (PPO)-l,4-bis[2-(4-methyl-5-phenyloxazolyl]ben- 
zene (POPOP)  toluene. Each experimental result is the average of four different cultures. 
Preparation of TItF.--Extracts from calf thymus were prepared  and dialyzed  according 
to the procedure previously described (17). The preparations used were diluted  at a standard 
concentration of 1 mg of protein per ml. Extracts of calf lymph  node and  calf spleen were 
prepared by similar procedures and were used at the same protein  concentration. 
RESULTS 
Effect of THF on the Two Phases of In  Vitro Sensitization of Lymphoid Cells 
against Syngeneic Tumor Cells.--In the first experiments we tested the effect of 
THF  on  in  vitro  sensitization  of  C57BL  spleen  cells  against  3LL  syngeneic 
tumor cells. For this purpose spleen cells were exposed to tumor cell monolayers 
for  a  4  day  period.  These  lymphoid  cells  were  then  recovered,  washed  by 
repeated  centrifugation,  and  dispensed  at  a  concentration  of  2,000  or  5,000 
living cells per 10 ~1 into the wells of the standard  microplates used. The wells 
were seeded 24 h  earlier with 3LL tumor cells, and by the time of their exposure 
to lymphocytes, contained from 50 to 100 target cells, according to the different 
experiments  performed.  24  h  after  exposure,  the  number  of  tumor  cells  re- 
maining  in  each  well  was  recorded,  and  the  cytotoxicity index  calculated  on 
the basis  of the respective number  of target  cells counted  in  the experimental 
group compared  with that in  the control group  exposed  to unsensitized  spleer~ 
cells. 
THF  was  added  at  a  2 %  concentration  to  the  culture  medium,  since  this 
has been found adequate to restore the immunological competence of lymphoid 
cells  in  previous  experiments  when  the  in  vitro  GVHR  was  measured  (18). 1524  ACTION OF  THF  ON  IN  VITRO  SENSITIZATION 
Each standard experiment included spleen cells both sensitized and assayed in 
the presence of THF, spleen cells sensitized only or assayed only in the presence 
of THF, and spleen ceils sensitized and assayed in the absence of THF. Table I 
summarizes the results of four consecutive experiments. It can be seen that: 
(a) THF present during both phases of the reaction increased the cytotoxicity 
mediated by sensitized lymphOid cells; (b)  similarly, THF, added during the 
sensitization phase only, promoted further cytotoxicity of the spleen cells; (c) 
TABLE  I 
Effect of THF on the Two Phases of In Vitro Sensitization  of C57BL Spleen Cells against 3LL 
Syngeneie  Tumor Cells 
THF  THF 
Exp.  no. of C57BL  Sensitizing  during  during  Mean =t: SE of 3LL  Cytotoxlcity 
spleen cells  cells,  sensiti-  effector  target cells*  of 3LL  P:~ 
zation  phase  target cells 
% 
1  5,000  3LL  +  +  7.3  4-  1.3  73  +++ 
5,000  "  +  --  15.3  4- 2.6  43  + 
5,000  "  --  +  20.7  4-  5.5  22  NS 
fi,000  "  --  --  25.3  4-  5.1  5 
2  2,000  3LL  +  +  135.0  -¢- 20.4  42  ++ 
2,000  "  +  --  190.1  +  13.7  18  + 
2,000  "  --  --  239.6  -4-  15.8  --3 
5,000  3LL  +  +  83.1  4-  5.1  56  ++ 
5,000  "  +  --  94.6  4-  4.0  50  + 
5,000  "  --  +  98.2  4-  4.8  48  NS 
5,000  "  --  --  107.7  -4-  5.9  43 
5,000  3LL  +  --  37.0  -4- 3.2  24  + 
5,000  "  --  +  48.1  4-  4.9  1  NS 
5,000  "  --  --  47.1  4-  4.8  3 
+, _P <  0.05; ++,  P  <  0.01; +++,  P  <  0.001; NS, P  >  0.05. 
* SE, standard error of the mean number of surviving 3LL target cells. 
:~ Probability computed by Student's t test compared with percent cytotoxicity of spleen 
cells sensitized and assayed without THF. 
no increased cytotoxicity was detected when THF was added during the effector 
phase only; and (d) THF was more effective when present during both phases 
of the reaction than when added during sensitization only. 
It  seems,  therefore,  that  THF  acts  more  predominantly upon  the  steps 
Ieading to production of specifically sensitized lymphocytes rather than on the 
expression of cytotoxicity itself. Moreover, as can be seen from exps. 1, 2, and 
4  (Table I), THF discloses more striking effects when added  to  cell cultures 
relatively poorly  reactive  by  themselves,  than  when  added  to  cell  cultures 
with  a  high  cytotoxicity index  (exp.  3,  Table I).  This suggests  the  possible C.  CARNAUD,  D.  ILFELD,  I.  BROOK,  AND  N.  TRAININ  1525 
existence of a  ceiling level for in vitro reactivity of normal spleen cells, which 
once reached, cannot be exceeded by further addition of THF. 
Finally, it is interesting to mention that the presence of THF does not modify 
the viability and number of lymphoid cells maintained in culture nor does it 
increase the percentage of large blastoid cells found (Table II). It can be seen 
that the number of viable lymphoid cells and the percentage of large blastoid 
cells recovered per plate remained unaffected, whether or not THF had been 
added to the cultures. 
Lack of Effect of THF on  Unsensitized Lympkocytes or on Lymphocytes Sen- 
sitized against Transplantation Antigens Unrelated to Those of the Target Cells.- 
In the light of the above results it was critical to test whether THF induces or 
increases cell killing when  added  to lymphoid cells not previously sensitized 
against 3LL tumor target cells.  As shown in Table III, exps. 1, 2,  and 3,  the 
TABLE  II 
Number o] Viable Lymphoid Cells and Percentage of Large Blastoid Cells Reco~ered after 
Sensitization  with THF 
Exp.  Sensitizing cells  THF during  no. of live lymphoid cells  Percentage of large 
sensitization  recovered per plate  blastoid cells 
% 
1  3LL  +  3.8  X  10 n  20 
"  --  3.4  X  106  25 
2  3LL  +  4.2  X  106  16 
"  --  5.2  X  106  14 
3  3LL  -k  2.5  X  106  26 
"  --  3.1  X  106  28 
addition of 2 % THF to unsensitized spleen cells did not modify the number of 
target cells counted in the respective wells. In exp. 4, Table III, C57BL spleen 
cells were sensitized either against 3LL  tumor cells or against rat fibroblasts 
and assayed for cytotoxicity against 3LL target cells. It can be seen that the 
selective addition of THF in the reaction against xenogeneic antigens did not 
affect the nonspecific cytotoxicity, which is usually found under  these condi- 
tions of sensitization (11). 
Specificity  of the Effect Mediated by THF.--It  was important,  at  this stage 
of the investigation,  to test whether  the increased  cytotoxicity mediated  by 
in  vitro sensitized  lymphocytes in  the presence of THF  was or  was not  ex- 
clusive to thymic extracts. With this aim in view, spleen and lymph node ex- 
tracts of calf origin were prepared by a procedure similar to that described for 
THF and  tested in  parallel  with  THF.  As seen in  Table IV, in  contrast  to 
thymus extracts, neither spleen extract tested on lymphoid cells from normal 
mice (exps. 1 and 2), nor lymph node extract added  to spleen cells from neo- 1526  ACTION  OF  TH]~  ON  IN  VITRO  SENSITIZATION 
natally thymectomized donors (Table IV,  exp.  3),  had  any significant effect 
on the in vitro cell-mediated reaction. These results clearly indicate that THF 
activity upon in vitro sensitization of lymphoid cells is organ specific. 
Identification  of the Lymphoid  Cell  Population  Activated  by  THF.--The  ex- 
perimental conditions described above did not provide information about the 
type of lymphocyte population responsible for in vitro sensitization and cyto- 
toxicity,  and,  therefore,  did  not permit identification of  the  cell  specifically 
activated by THF in this reaction. Accordingly, instead of normal spleen cells, 
TABLE III 
Lack of Effect of THF on Unsensitized Spleen Cells and on Spleen Cdls Sensitized  against Rat 
BN Fibroblasts 
Exp.  no. of C57BL  Sensitizing  THF during  THF during  Mean -4- SE of  Cytotoxicity 
spleen cells  ceils  sensitization  effector  3LL target  cells  of 3LL target  P* 
phase  cells 
% 
1  2,000  None  --  +  232.0  -4-  14.3 
2,000  "  --  --  232.5  -4- 20.4 
2  5,000  None  --  +  20.5  ±  2.0 
5,000  "  --  --  20.4  ±  3.4 
3  5,000  None  --  +  46.8  -4-  5.1 
5,000  "  --  --  48.6  -4- 4.2 
4  5,000  3LL  --  --  107.7  ±  5.9 
5,000  RatBN  +  +  137.5  ±  8.0 
5,000  "  "  +  --  139:8  ±  15.2 
5,000  "  "  --  +  135.7  4-  14.8 
5,000  "  "  --  --  138.3  ±  9.5 
43  ++ 
27  NS 
26  NS 
28  NS 
27 
++, P  (  0.01; NS, P  >  0.05. 
* Probability computed by Student's t test compared with percent cytotoxicity of spleen 
cells sensitized against rat BN fibroblasts on the absence of THF. 
which contain a mixture of T  and B  lymphocytes, we used more defined popu- 
lations-either T  or B  cells produced according to accepted procedures  (19). 
For this purpose, adult thymectomized, lethally irradiated C57BL mice were 
injected with  either  syngeneic bone marrow  cells  or  syngeneic thymocytes. 
8-10 days later, spleen cells from these animals were recovered and tested for 
in vitro sensitization. The homogeneity of these lymphoid cell populations was 
previously checked  by their sensitivity or resistance to  anti-0 serum and by 
their reactivity to Con A  stimulation. As seen in Table V, 91% of the spleen 
cells  recovered  from  animals restored  with  thymocytes  were  0-positive  and 
showed normal reactivity to Con A. On the other hand, spleen cells from mice 
reconstituted with  bone marrow ceils disclosed  a  residual T-cell presence of 
only 4 % and did not react to Con A. These respective T  and B  ceils were then C.  CARNAUD,  D.  ILFELD,  I.  BROOK,  AND  N.  TRAININ  1527 
TABLE  IV 
Effect of Thymus  (THF), Spleen (SE), and Lymph Node (LNE) Extracts on 
In Vitro Sensitization 
no. of  Exp.  C57BL spleen  Sensitizing  Sensitization  Effector  Mean :t: SE of 3LL  Cytotoxicity of  p, 
cells  monolayer  phase  phase  target cells  3LL target cells 
% 
5,000  3LL  THF  THF  27.7  --t- 2.7  62  ++ 
5,000  "  SE  SE  37.3  4-  3.3  49  NS 
5,000  "  --  --  40.0  -4-  2.5  46 
5,000  None  --  THF  69.0  -4-  5.8  7  +++ 
5,000  "  --  SE  63.3  -4-  7.7  14 
5,000  "  --  --  73.8  4-  7.0  0 
5,000  3LL  THF  THF  19.8  -4-  2.0  38  ++ 
5,000  "  SE  SE  40.2  -4-  10.4  --27  NS 
5,000  "  THF  --  24.8  -4-  3.3  22  + 
5,000  "  SE  --  35.2  q-  3.7  --10  NS 
5,000  "  --  --  33.1  4-  3.8  --3 
3~  5,000  3LL  THF  THF  7.2  ±  4.4  82  +  + 
5,000  "  LNE  LNE  26.6  -4-  2.8  35  NS 
5,000  "  --  --  24.1  -¢-  3.6  34 
+, P  <  0.05; ++,  P  <  0.01; +++,  P  <  0.001; NS, P  >  0.05. 
* Probability computed by Student's t test compared with percent cytotoxicity of spleen 
cells sensitized and assayed without extract. 
Experiment performed with spleen cells from neonatally thymectomized C57BL mice. 
TABLE  V 
Sensitivity of Spleen Cells from Animals  Restored  with  Thymocytes or Bone Marrow Cells  to 
A nti-O Serum and Con A 
Spleen cells*  Percentage of  cpm without Con A  cpm with Con A  O-positive  cells 
% 
T  91  1,478  +  96  50,578  q-  5,801 
B  4  901  -¢-  157  2,822  ±  423 
* Spleen  cells  recovered from  adult  thymectomized,  lethally  irradiated  (750  R)  mice 
restored with either 50 X  106 thymocytes (T) or 30 X  106 bone marrow cells (B). 
cultured  separately  on  3LL  tumor  monolayers  and  assayed  for  cytotoxicity. 
The  results shown in Table VI indicate that  while T  cells were responsible for 
in  vitro  sensitization  and  cytotoxicity,  B  cells  were  totally  inactive,  at  both 
concentrations  of  lymphoid  cells  tested.  Another  indication  suggesting  T-cell 
involvement  in this reaction was  that  by the end of sensitization, 33 %  of the 
T  lymphoid  cells tested were  transformed into large blastoid cells,  whereas an 
increase  of only 4 %  was  found  when B  cells were  tested. 1528  ACTION  OF  THF  ON  IN  VITRO  SENSITIZATION 
TABLE  VI 
Reactivity  of T and B  Spleen  Cells Sensitized  In Vitro against  3LL Tumor Cells 
Spleen  Sensitizing  Large  2 X  ]9 spleen cells/well  104 spleen cells/well 
bhstold 
cells*  cells  cells  Mean -~ SE 3LL  Cytotoxlcity~t  Mean 4- SE 3LL  Cytotoxicity~t 
target cells  target cells 
%  %  % 
T  3LL  37  87.3  4-  10.5  22  +  28.0  4-  3.5  49  ++ 
T  None  4  112.3 4-  8.5  55.1 4-  4.7 
B  3LL  14  125.8 4-  10.4  --6 NS  47.9  4-  2.8  10 NS 
B  None  10  118.8  4-  14.2  53.5  4-  5.5 
++, P  <  0.01; +, P  <  0.05; NS, P  >  0.05. 
* See footnote Table V. 
$ Probability computed by Student's  t test compared with percent cytotoxicity of un- 
sensitized @een cells. 
The next step in this investigation consisted of testing THF activity directly, 
either on T  or on B  cells sensitized in vitro. As seen in Table VII, the addition 
of THF to T  cells or to thymocytes (exps. 1 and 2, respectively) resulted in a 
significant increase in the reactivity of these cells against 3LL tumor targets. 
In contrast to these findings, the lack of B-cell reactivity remained unmodified 
in the presence of THF. 
In  conclusion,  these  experiments  clearly indicate  that  (a)  T  cells  are  the 
responsible  instrument  of  sensitization  in  vitro,  and  (b)  THF  can  directly 
potentiate  the  reactivity  of  these  cells,  when  measured  by  their  degree  of 
cytotoxicity. 
DISCUSSION 
The use of a complete in vitro model of cell-mediated immunity provides an 
adequate tool to study the processes by which unprimed lymphocytes become 
sensitized and give rise to a population of effector cells specifically committed. 
We had previously shown  that contact between  C57BL spleen cells and 3LL 
tumor  cell  monolayers generated  specifically sensitized  lymphocytes,  able  to 
mediate  cytotoxicity against  target  cells  identical  with  the  sensitizing  cells 
(ll). This model was, therefore, considered adequate to study the influence of 
THF on lymphocytes involved in  cell-mediated reactions.  In  the present ex- 
periments, spleen  cells sensitized  and  assayed for cytotoxicity in  culture  me- 
dium supplemented with THF were found to be significantly more cytotoxic 
than spleen cells cultured in normal medium. Moreover, when THF was selec- 
tively added, either during the phase of generation of sensitized lymphocytes, 
or during the effector phase, it was observed that THF exerts its activity during 
the sensitization phase only. Still,  in almost every experiment performed, the 
cytotoxicity index of spleen cells cultured with THF during both phases of the 
reaction  was  higher  than  that  of spleen  cells  activated  by THF  during  the C.  CARNAUD,  D.  ILFELD,  I.  BROOK,  AND  N.  TRAININ  1529 
TABLE VII 
Effect of THF on  T  and B  Lymphoid Cells  or on  Thymocytes Sensitized In  Vitro against 3LL 
Syngeneic  Tumor Cells 
THF  THF  no. of  Cytotoxi- 
Lymphoid  Sensitizing  during  during  Mean 4- SE 3LL  city of  lymphoid  _P  Exp.  cells  cells  sensitize- effector  cells/weU  target cells  3LL target 
tion  phase  cells 
% 
1  T*  3LL  +  --  5,000  218  .4-  23  51  +++ 
T  "  --  --  5,000  300  .4-  19  33  +++ 
T  None  --  --  5,000  449  .4-  24  0 
B*  3LL  +  --  5,000  359  4-  47  --28  NS 
B  "  --  --  5,000  318  -4-  60  --14  NS 
B  None  --  --  5,000  279  .4-  45 
2  Thymocytes  3LL  +  +  15,000  125.9  -4-  10.8  42  + 
"  "  --  --  15,000  180.5  .4-  23.7  16  NS 
"  None  --  +  15,000  243.1  .4-  37.9  --13 
"  "  --  --  15,000  215.4  .4-  31.7  0 
B~  3LL  +  +  15,000  151.5  4-  12.0  --24 
B  "  --  --  15,000  131.7  .4-  11.3  --8 
B  None  --  +  15,000  132.3  -4-  6.1  --9 
B  None  --  --  15,000  121.8  .4-  6.8  0 
* Spleen  cells  recovered from  adult  thymectomized,  lethally  irradiated  (750 
restored with either 50 X  106 thymocytes or 30  X  106 bone marrow cells. 
Spleen  cells  recovered  from  adult  thymectomized,  lethally  irradiated  (950 
restored with 30  X  106 bone marrow cells. 
R)  mice 
R)  mice 
sensitization phase  only. A  possible explanation for this finding is that  by the 
end of the 4  day culture period with THF  (sensitization phase), there were still 
lymphocytes  in  the  process  of sensitization,  requiring  the further  presence  of 
THF  in order to become effector cells for cytotoxicity.  Conversely, in  the  ab- 
sence of THF,  the  process  of sensitization  is probably  completed  by  the  end 
of the 4 day culture period, and the number of effector cells already determined. 
Thus,  the addition  of THF  during  the cytotoxicity assay only may occur too 
late or be too short in time to affect the outcome of the test. 
We  also  found  that  THF  specifically  increases  cytotoxicity  against  target 
cells  bearing  transplantation  antigens  identical  with  those  of  the  sensitizing 
cells. Indeed, when THF  was added to spleen cells sensitized against nonrelated 
antigens,  or to  unsensitized  spleen  cells, no increased  cytotoxicity was found. 
This indicates  that THF  does not increase indiscriminate  killing by sensitized 
lymphocytes, nor does it trigger an unprimed spleen cell population to potential 
cytotoxic capacity.  As controls  to  thymic extracts,  we have tested  several ex- 
tracts from calf lymphoid organs prepared  by a  procedure  similar to that used 
for THF.  No activity was detected in spleen or lymph node extracts, suggesting 1530  ACTION  OF  THF  ON  IN  VITRO  SENSITIZATION 
that the active compound is confined to, or at least present at an active con- 
centration in, the thymus only. Since all the experiments described were carried 
out with culture medium supplemented with  15 % fetal calf serum, the possi- 
bility that THF acts as a mere xenogeneic stimulus seems rather improbable. 
A  THF-like activity has been detected in the serum of some mammals  (20) 
and in particular in calf serum (21). It is therefore possible that the differences 
in activity between serum batches vis-A-vis in vitro stimulation of lymphocytes 
depends upon the amount of thymic factor present in the batches. 
Cell-mediated responses have been found to depend mainly on T-lymphocyte 
function. However, a recent report indicates that B  cells may also participate 
in such reactions, involving in particular the rejection of syngeneic tumor cells 
(22). It was therefore of interest to investigate which is the type of lymphocyte 
engaged in sensitization and cytotoxicity in the present system in which tumor 
cells were challenged with syngeneic spleen cells. When adult thymectomized, 
lethally irradiated mice were restored with either bone marrow cells or thymo- 
cytes, we observed that the spleen cells from T-restored animals were active 
against  the  tumor  cells,  while  spleen  cells  from B  animals  did  not  mediate 
significant cytotoxicity. These findings are in accordance with those obtained 
by other investigators using  similar or slightly different systems of in  vitro 
sensitization against fibroblasts (9) or lymphocytes of allogeneic origin (23). 
Although  the  role of a  thymic humoral  component in  the chain of events 
leading  to  immunologically competent T  lymphocytes has  been  well  estab- 
lished, the precise stage at which this humoral factor is active is still unclear. 
Several reports suggest that thymus hormone would act upon prethymic ele- 
ments still devoid of thymus antigenic markers (24, 25). On the other hand, 
previous observations from this laboratory indicate that THF activates a post- 
thymic cell population (7, 26). The present effect of THF upon in vitro sensi- 
tization could be explained either by activation of non-T precursor cells present 
in the normal spleen and their transformation into active T lymphocytes, or by 
direct interaction with T  cells themselves, which leads to an increase in their 
immunological competence. Our present results indicate that the effect of THF 
is exerted on T  cells rather than on ]3 cells,  since T-restored spleen cells were 
found to be more cytotoxic when sensitized in the presence of THF. This was 
further supported by the finding that thymocytes, which are poorly reactive 
in themselves, became as cytotoxic as mature T  cells when tested in the pres- 
ence of THF. Still, the possibility of an increase in newly differentiated T  cells 
out of the B spleen cell population, too small to be detected under the present 
experimental conditions, cannot be totally discarded. 
All the results presently reported have been obtained by the use of in vitro 
procedures.  More  information using  in  vivo models  is  required  in  order  to 
understand  the general  significance of the role of THF in cell-mediated im- 
munity. C.  CARNAUD, D.  IL]FELD, I. BROOK, AND N.  TRAININ  1531 
SUMMARY 
Unprimed mouse spleen cells cultured in vitro on syngeneic tumor cell mono- 
layers have been  previously shown  to  become specifically sensitized  and  to 
mediate cytotoxicity against  the  same type of tumor cells. This complete in 
vitro system of cell-mediated response has been presently used to test the effect 
of a  thymic humoral factor (THF) upon the differentiation process leading to 
the  generation  of  specifically  committed  lymphocytes.  Culture  media  were 
supplemented with 2 %  THF during either the sensitization or effector phase, 
or both phases of the reaction. Whereas the addition of THF during both phases 
or during sensitization only resulted in a significant increase in the cytotoxicity 
index, THF added during  the effector phase was ineffective. The behavior of 
unsensitized spleen cells and of spleen cells sensitized against nonrelated trans- 
plantation  antigens  remained  unmodified  by THF.  After  showing  that  the 
entire reaction is mediated by lymphocytes of thymic origin, THF was directly 
tested on T  or B spleen cells. It was found that only T  cells reacted to THF by 
an increased cytotoxic capacity, while B  cells remained inactive after addition 
of THF. It was therefore concluded that THF activates a postthymic popula- 
tion of lymphoid cells, transforming them into fully competent lymphocytes. 
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